BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Deals

Quark, Silence Therapeutics deal

Silence received a $1.5 million milestone payment from Quark. The payment was triggered after Quark granted Novartis AG (NYSE:NVS; SIX:NOVN, Basel Switzerland) an option to license exclusive, worldwide...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >